FR2347051A1 - Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant - Google Patents

Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant

Info

Publication number
FR2347051A1
FR2347051A1 FR7610455A FR7610455A FR2347051A1 FR 2347051 A1 FR2347051 A1 FR 2347051A1 FR 7610455 A FR7610455 A FR 7610455A FR 7610455 A FR7610455 A FR 7610455A FR 2347051 A1 FR2347051 A1 FR 2347051A1
Authority
FR
France
Prior art keywords
virus
inactivation
alkylating agent
vaccines
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7610455A
Other languages
English (en)
Other versions
FR2347051B1 (fr
Inventor
Louis Dhennin
Bertrand Larenaudie
Michele Remond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7610455A priority Critical patent/FR2347051A1/fr
Priority to DE19772714258 priority patent/DE2714258A1/de
Priority to ES458038A priority patent/ES458038A1/es
Priority to BE176541A priority patent/BE853395A/fr
Priority to IT67782/77A priority patent/IT1082492B/it
Publication of FR2347051A1 publication Critical patent/FR2347051A1/fr
Application granted granted Critical
Publication of FR2347051B1 publication Critical patent/FR2347051B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/187—Hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7610455A 1976-04-09 1976-04-09 Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant Granted FR2347051A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR7610455A FR2347051A1 (fr) 1976-04-09 1976-04-09 Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant
DE19772714258 DE2714258A1 (de) 1976-04-09 1977-03-31 Verfahren zur herstellung von immunstoffen gegen die schweinepest und die immunstoffe enthaltende impfstoffe
ES458038A ES458038A1 (es) 1976-04-09 1977-04-06 Procedimiento para la preparacion de agentes inmunogenos contra la peste porcina.
BE176541A BE853395A (fr) 1976-04-09 1977-04-08 Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant
IT67782/77A IT1082492B (it) 1976-04-09 1977-04-08 Procedimento per la preparazione di agenti immunogeni contro la peste porcina e vaccino contenente tali agenti

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7610455A FR2347051A1 (fr) 1976-04-09 1976-04-09 Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant

Publications (2)

Publication Number Publication Date
FR2347051A1 true FR2347051A1 (fr) 1977-11-04
FR2347051B1 FR2347051B1 (fr) 1979-10-12

Family

ID=9171638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610455A Granted FR2347051A1 (fr) 1976-04-09 1976-04-09 Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant

Country Status (5)

Country Link
BE (1) BE853395A (fr)
DE (1) DE2714258A1 (fr)
ES (1) ES458038A1 (fr)
FR (1) FR2347051A1 (fr)
IT (1) IT1082492B (fr)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOL. 62, 1980G 1965 ) *

Also Published As

Publication number Publication date
ES458038A1 (es) 1978-03-16
DE2714258A1 (de) 1977-10-20
FR2347051B1 (fr) 1979-10-12
BE853395A (fr) 1977-10-10
IT1082492B (it) 1985-05-21

Similar Documents

Publication Publication Date Title
ZA91559B (en) Vaccines against cancer and infectious diseases
EP0330359A3 (fr) Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
KR930703362A (ko) 병원체로부터 얻은 항원성 폴리오사이드로부터 유도된 올리고사이드
IS4703A (is) Þáttur er örvar griplufrumur
ES487046A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados
GB1161333A (en) Animal Vaccine
GT197854594A (es) Vacuna contra haemophilus influenzae
GB1059676A (en) Process for stabilising biologically active proteinaceous materials
SE7512828L (sv) Calicivirusvaccin
Beardsley Phage production by crown-gall bacteria and the formation of plant tumors
FR2347051A1 (fr) Procede de preparation d'agents immunogenes contre la peste porcine et vaccins les contenant
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.
SE9903534L (sv) Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
GB953992A (en) Vaccine products and method of preparing same
GB895073A (en) Immunising preparations containing clostridium perfringens toxins and toxoids
GB1481650A (en) Chemical processes and products
FR2047886A1 (en) Non-toxic anti-whooping cough vaccine
FR2270891A2 (en) Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria
JPS5344620A (en) Recovering of immobilized vaccine and specific antigen
FR2010678A1 (en) Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis
ES226832A1 (es) Un procedimiento para producir un producto de vacuna contra la poliomelitis
SU70583A1 (ru) Способ лечени микробных инфекций
GB770852A (en) Vaccine products and process of producing the same

Legal Events

Date Code Title Description
ST Notification of lapse